Sun, 3 January 2021
Two distinguished scientists join me for a discussion of the optimal public-health response to the challenges posed by COVID-19.
Martin Kulldorff is a Professor of Medicine at Harvard Medical School. His research centers on developing new epidemiological and statistical methods for the early detection and monitoring of infectious disease outbreaks and for post-market drug and vaccine safety surveillance.
Eric Topol is a Professor of Molecular Medicine at Scripps Research, founder and director of its Translational Research Institute, a practicing physician, and one of the top 10 cited medical researchers.